PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 184 filers reported holding PTC THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,148,739 | -19.0% | 140,506 | +47.0% | 0.00% | 0.0% |
| Q2 2023 | $3,888,377 | +42.3% | 95,608 | +69.5% | 0.00% | – |
| Q1 2023 | $2,732,016 | +95.6% | 56,400 | +54.1% | 0.00% | – |
| Q4 2022 | $1,396,831 | -94.6% | 36,595 | -92.9% | 0.00% | -100.0% |
| Q3 2022 | $25,938,000 | +193.7% | 516,685 | +134.3% | 0.01% | +150.0% |
| Q2 2022 | $8,832,000 | +151.1% | 220,495 | +133.8% | 0.00% | +100.0% |
| Q1 2022 | $3,518,000 | +249.0% | 94,307 | +272.7% | 0.00% | – |
| Q4 2021 | $1,008,000 | +321.8% | 25,301 | +294.6% | 0.00% | – |
| Q3 2021 | $239,000 | -89.9% | 6,412 | -88.6% | 0.00% | – |
| Q2 2021 | $2,372,000 | -53.0% | 56,123 | -47.3% | 0.00% | -100.0% |
| Q1 2021 | $5,046,000 | +65.7% | 106,576 | +113.5% | 0.00% | 0.0% |
| Q4 2020 | $3,045,000 | +33.8% | 49,910 | +2.6% | 0.00% | – |
| Q3 2020 | $2,275,000 | -37.9% | 48,659 | -32.6% | 0.00% | -100.0% |
| Q2 2020 | $3,663,000 | -45.2% | 72,182 | -51.8% | 0.00% | -33.3% |
| Q1 2020 | $6,685,000 | -90.4% | 149,858 | -89.6% | 0.00% | -90.0% |
| Q4 2019 | $69,525,000 | -8.6% | 1,447,518 | -35.6% | 0.03% | -16.7% |
| Q3 2019 | $76,075,000 | -9.2% | 2,249,416 | +20.8% | 0.04% | -7.7% |
| Q2 2019 | $83,814,000 | +4.6% | 1,862,544 | -12.5% | 0.04% | 0.0% |
| Q1 2019 | $80,098,000 | +25.7% | 2,127,995 | +14.6% | 0.04% | +11.4% |
| Q4 2018 | $63,713,000 | +132.0% | 1,856,453 | +217.7% | 0.04% | +169.2% |
| Q3 2018 | $27,464,000 | +209.9% | 584,375 | +122.4% | 0.01% | +160.0% |
| Q2 2018 | $8,862,000 | +294.9% | 262,711 | +216.8% | 0.01% | – |
| Q1 2018 | $2,244,000 | -49.2% | 82,924 | -68.7% | 0.00% | -100.0% |
| Q4 2017 | $4,417,000 | +17.8% | 264,831 | +41.4% | 0.00% | 0.0% |
| Q3 2017 | $3,748,000 | +105.4% | 187,300 | +88.1% | 0.00% | +200.0% |
| Q2 2017 | $1,825,000 | +61.8% | 99,551 | -13.2% | 0.00% | – |
| Q1 2017 | $1,128,000 | +34.4% | 114,642 | +49.1% | 0.00% | -100.0% |
| Q4 2016 | $839,000 | -57.9% | 76,900 | -46.0% | 0.00% | -50.0% |
| Q3 2016 | $1,994,000 | +105.6% | 142,342 | -5.5% | 0.00% | +100.0% |
| Q1 2016 | $970,000 | +13.3% | 150,594 | +469.9% | 0.00% | 0.0% |
| Q4 2015 | $856,000 | -82.0% | 26,426 | -85.2% | 0.00% | -80.0% |
| Q3 2015 | $4,755,000 | -60.1% | 178,124 | -28.2% | 0.01% | -50.0% |
| Q2 2015 | $11,932,000 | +382.7% | 247,916 | +510.3% | 0.01% | +400.0% |
| Q1 2015 | $2,472,000 | -81.3% | 40,625 | -84.1% | 0.00% | -84.6% |
| Q4 2014 | $13,210,000 | +25.9% | 255,179 | +7.1% | 0.01% | +18.2% |
| Q3 2014 | $10,490,000 | +227.2% | 238,342 | +94.3% | 0.01% | +175.0% |
| Q1 2014 | $3,206,000 | – | 122,692 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 7,235,196 | $162,140,742 | 3.42% |
| Camber Capital Management LP | 3,400,000 | $76,194 | 2.51% |
| ARMISTICE CAPITAL, LLC | 6,150,000 | $137,821,500 | 2.11% |
| GREAT POINT PARTNERS LLC | 500,000 | $11,205,000 | 2.04% |
| COWEN AND COMPANY, LLC | 799,511 | $17,917,041 | 1.25% |
| GEORGE KAISER FAMILY FOUNDATION | 45,816 | $6,491,211 | 1.22% |
| SPHERA FUNDS MANAGEMENT LTD. | 218,459 | $4,895,666 | 0.89% |
| SECTORAL ASSET MANAGEMENT INC | 187,016 | $4,191,029 | 0.82% |
| Nebula Research & Development LLC | 21,858 | $489,838 | 0.26% |
| Phocas Financial Corp. | 64,701 | $1,450,000 | 0.21% |